Difficult Conversations and Painful Decisions: When Should Patients with Progressive Cancer Stop Chemotherapy? ()
Affiliation(s)
1Sibley Memorial Hospital, Johns Hopkins Medicine, Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery, ashington, USA.
2Massachusetts General Hospital, Harvard Medical School, Division of Gynecologic Oncology, Boston, USA.
3Massachusetts General Hospital, Harvard Medical School, Division of Palliative Care and Geriatric Medicine, Boston, USA.
ABSTRACT
Introduction: The decision to stop anti-cancer treatment is fraught with many
challenges for the oncologist, the patient, and their caregivers. This review
examines the special considerations surrounding the decision to cease
chemotherapy in terminally ill cancer patient. Methods: A comprehensive
literature search was conducted to find relevant publications on chemotherapy
cessation. A total of 2700 records were retrieved and 141 were identified as
eligible for inclusion in this review. Results: Palliative chemotherapy
does not achieve the goal of tumor-related symptom reduction for patients who
have experienced progressive disease with more than two prior lines of
chemotherapy. ECOG performance status is a crucial predictor of response to
therapy and chemotherapy-related complications. Challenges to stopping
chemotherapy at the end of life are multifactorial and are both patient and
physician-driven. Racial, ethnic, and income-based disparities are seen in the
timing and quality of end-of-life conversations offered by physicians to their
patients. Conclusions: The decision to cease chemotherapy is one that
should be approached with careful consideration and accurate information. Clear
communication, compassion and empathy are important components to the
therapeutic relationship. Early involvement of palliative care and clear
conversations about prognosis and the expected utility of further chemotherapy is
essential to conduct the best possible care for cancer patients at the end of life.
Share and Cite:
Staples, J. , Mazina, V. , Daubman, B. and Goodman, A. (2022) Difficult Conversations and Painful Decisions: When Should Patients with Progressive Cancer Stop Chemotherapy?.
Journal of Cancer Therapy,
13, 20-47. doi:
10.4236/jct.2022.131003.
Cited by
No relevant information.